The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Praziquantel API Market Research Report 2025
Synopsis
The global Praziquantel API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Praziquantel API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Praziquantel API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Praziquantel API include Enal Drugs, Shilpa Medicare, FENGCHEN GROUP, Shree Ganesh Remedies, ZumVet, Clearsynth, Neutral Pharma, Justdial and ECHEMI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Praziquantel API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Praziquantel API.
Report Scope
The Praziquantel API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Praziquantel API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Praziquantel API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Enal Drugs
Shilpa Medicare
FENGCHEN GROUP
Shree Ganesh Remedies
ZumVet
Clearsynth
Neutral Pharma
Justdial
ECHEMI
PharmaSources
Enomark
Shanghai New Hualian
Nanjing Pharmaceutical FACTORY
Wuhan Xingzhongcheng Technology
Zhejiang Hisun Pharmaceutical
Segment by Type
0.985
0.99
Segment by Application
Animal Husbandry
Pet Medicine
Medicines For Human Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Praziquantel API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Praziquantel API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Praziquantel API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Praziquantel API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Praziquantel API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Praziquantel API include Enal Drugs, Shilpa Medicare, FENGCHEN GROUP, Shree Ganesh Remedies, ZumVet, Clearsynth, Neutral Pharma, Justdial and ECHEMI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Praziquantel API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Praziquantel API.
Report Scope
The Praziquantel API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Praziquantel API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Praziquantel API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Enal Drugs
Shilpa Medicare
FENGCHEN GROUP
Shree Ganesh Remedies
ZumVet
Clearsynth
Neutral Pharma
Justdial
ECHEMI
PharmaSources
Enomark
Shanghai New Hualian
Nanjing Pharmaceutical FACTORY
Wuhan Xingzhongcheng Technology
Zhejiang Hisun Pharmaceutical
Segment by Type
0.985
0.99
Segment by Application
Animal Husbandry
Pet Medicine
Medicines For Human Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Praziquantel API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Praziquantel API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Praziquantel API Market Overview
1.1 Product Overview and Scope of Praziquantel API
1.2 Praziquantel API Segment by Type
1.2.1 Global Praziquantel API Market Value Comparison by Type (2024-2030)
1.2.2 0.985
1.2.3 0.99
1.3 Praziquantel API Segment by Application
1.3.1 Global Praziquantel API Market Value by Application: (2024-2030)
1.3.2 Animal Husbandry
1.3.3 Pet Medicine
1.3.4 Medicines For Human Use
1.4 Global Praziquantel API Market Size Estimates and Forecasts
1.4.1 Global Praziquantel API Revenue 2019-2030
1.4.2 Global Praziquantel API Sales 2019-2030
1.4.3 Global Praziquantel API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Praziquantel API Market Competition by Manufacturers
2.1 Global Praziquantel API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Praziquantel API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Praziquantel API Average Price by Manufacturers (2019-2024)
2.4 Global Praziquantel API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Praziquantel API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Praziquantel API, Product Type & Application
2.7 Praziquantel API Market Competitive Situation and Trends
2.7.1 Praziquantel API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Praziquantel API Players Market Share by Revenue
2.7.3 Global Praziquantel API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Praziquantel API Retrospective Market Scenario by Region
3.1 Global Praziquantel API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Praziquantel API Global Praziquantel API Sales by Region: 2019-2030
3.2.1 Global Praziquantel API Sales by Region: 2019-2024
3.2.2 Global Praziquantel API Sales by Region: 2025-2030
3.3 Global Praziquantel API Global Praziquantel API Revenue by Region: 2019-2030
3.3.1 Global Praziquantel API Revenue by Region: 2019-2024
3.3.2 Global Praziquantel API Revenue by Region: 2025-2030
3.4 North America Praziquantel API Market Facts & Figures by Country
3.4.1 North America Praziquantel API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Praziquantel API Sales by Country (2019-2030)
3.4.3 North America Praziquantel API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Praziquantel API Market Facts & Figures by Country
3.5.1 Europe Praziquantel API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Praziquantel API Sales by Country (2019-2030)
3.5.3 Europe Praziquantel API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Praziquantel API Market Facts & Figures by Country
3.6.1 Asia Pacific Praziquantel API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Praziquantel API Sales by Country (2019-2030)
3.6.3 Asia Pacific Praziquantel API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Praziquantel API Market Facts & Figures by Country
3.7.1 Latin America Praziquantel API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Praziquantel API Sales by Country (2019-2030)
3.7.3 Latin America Praziquantel API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Praziquantel API Market Facts & Figures by Country
3.8.1 Middle East and Africa Praziquantel API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Praziquantel API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Praziquantel API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Praziquantel API Sales by Type (2019-2030)
4.1.1 Global Praziquantel API Sales by Type (2019-2024)
4.1.2 Global Praziquantel API Sales by Type (2025-2030)
4.1.3 Global Praziquantel API Sales Market Share by Type (2019-2030)
4.2 Global Praziquantel API Revenue by Type (2019-2030)
4.2.1 Global Praziquantel API Revenue by Type (2019-2024)
4.2.2 Global Praziquantel API Revenue by Type (2025-2030)
4.2.3 Global Praziquantel API Revenue Market Share by Type (2019-2030)
4.3 Global Praziquantel API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Praziquantel API Sales by Application (2019-2030)
5.1.1 Global Praziquantel API Sales by Application (2019-2024)
5.1.2 Global Praziquantel API Sales by Application (2025-2030)
5.1.3 Global Praziquantel API Sales Market Share by Application (2019-2030)
5.2 Global Praziquantel API Revenue by Application (2019-2030)
5.2.1 Global Praziquantel API Revenue by Application (2019-2024)
5.2.2 Global Praziquantel API Revenue by Application (2025-2030)
5.2.3 Global Praziquantel API Revenue Market Share by Application (2019-2030)
5.3 Global Praziquantel API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Enal Drugs
6.1.1 Enal Drugs Corporation Information
6.1.2 Enal Drugs Description and Business Overview
6.1.3 Enal Drugs Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Enal Drugs Praziquantel API Product Portfolio
6.1.5 Enal Drugs Recent Developments/Updates
6.2 Shilpa Medicare
6.2.1 Shilpa Medicare Corporation Information
6.2.2 Shilpa Medicare Description and Business Overview
6.2.3 Shilpa Medicare Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shilpa Medicare Praziquantel API Product Portfolio
6.2.5 Shilpa Medicare Recent Developments/Updates
6.3 FENGCHEN GROUP
6.3.1 FENGCHEN GROUP Corporation Information
6.3.2 FENGCHEN GROUP Description and Business Overview
6.3.3 FENGCHEN GROUP Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 FENGCHEN GROUP Praziquantel API Product Portfolio
6.3.5 FENGCHEN GROUP Recent Developments/Updates
6.4 Shree Ganesh Remedies
6.4.1 Shree Ganesh Remedies Corporation Information
6.4.2 Shree Ganesh Remedies Description and Business Overview
6.4.3 Shree Ganesh Remedies Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shree Ganesh Remedies Praziquantel API Product Portfolio
6.4.5 Shree Ganesh Remedies Recent Developments/Updates
6.5 ZumVet
6.5.1 ZumVet Corporation Information
6.5.2 ZumVet Description and Business Overview
6.5.3 ZumVet Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ZumVet Praziquantel API Product Portfolio
6.5.5 ZumVet Recent Developments/Updates
6.6 Clearsynth
6.6.1 Clearsynth Corporation Information
6.6.2 Clearsynth Description and Business Overview
6.6.3 Clearsynth Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Clearsynth Praziquantel API Product Portfolio
6.6.5 Clearsynth Recent Developments/Updates
6.7 Neutral Pharma
6.6.1 Neutral Pharma Corporation Information
6.6.2 Neutral Pharma Description and Business Overview
6.6.3 Neutral Pharma Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Neutral Pharma Praziquantel API Product Portfolio
6.7.5 Neutral Pharma Recent Developments/Updates
6.8 Justdial
6.8.1 Justdial Corporation Information
6.8.2 Justdial Description and Business Overview
6.8.3 Justdial Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Justdial Praziquantel API Product Portfolio
6.8.5 Justdial Recent Developments/Updates
6.9 ECHEMI
6.9.1 ECHEMI Corporation Information
6.9.2 ECHEMI Description and Business Overview
6.9.3 ECHEMI Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ECHEMI Praziquantel API Product Portfolio
6.9.5 ECHEMI Recent Developments/Updates
6.10 PharmaSources
6.10.1 PharmaSources Corporation Information
6.10.2 PharmaSources Description and Business Overview
6.10.3 PharmaSources Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PharmaSources Praziquantel API Product Portfolio
6.10.5 PharmaSources Recent Developments/Updates
6.11 Enomark
6.11.1 Enomark Corporation Information
6.11.2 Enomark Praziquantel API Description and Business Overview
6.11.3 Enomark Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Enomark Praziquantel API Product Portfolio
6.11.5 Enomark Recent Developments/Updates
6.12 Shanghai New Hualian
6.12.1 Shanghai New Hualian Corporation Information
6.12.2 Shanghai New Hualian Praziquantel API Description and Business Overview
6.12.3 Shanghai New Hualian Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai New Hualian Praziquantel API Product Portfolio
6.12.5 Shanghai New Hualian Recent Developments/Updates
6.13 Nanjing Pharmaceutical FACTORY
6.13.1 Nanjing Pharmaceutical FACTORY Corporation Information
6.13.2 Nanjing Pharmaceutical FACTORY Praziquantel API Description and Business Overview
6.13.3 Nanjing Pharmaceutical FACTORY Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Nanjing Pharmaceutical FACTORY Praziquantel API Product Portfolio
6.13.5 Nanjing Pharmaceutical FACTORY Recent Developments/Updates
6.14 Wuhan Xingzhongcheng Technology
6.14.1 Wuhan Xingzhongcheng Technology Corporation Information
6.14.2 Wuhan Xingzhongcheng Technology Praziquantel API Description and Business Overview
6.14.3 Wuhan Xingzhongcheng Technology Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Wuhan Xingzhongcheng Technology Praziquantel API Product Portfolio
6.14.5 Wuhan Xingzhongcheng Technology Recent Developments/Updates
6.15 Zhejiang Hisun Pharmaceutical
6.15.1 Zhejiang Hisun Pharmaceutical Corporation Information
6.15.2 Zhejiang Hisun Pharmaceutical Praziquantel API Description and Business Overview
6.15.3 Zhejiang Hisun Pharmaceutical Praziquantel API Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zhejiang Hisun Pharmaceutical Praziquantel API Product Portfolio
6.15.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Praziquantel API Industry Chain Analysis
7.2 Praziquantel API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Praziquantel API Production Mode & Process
7.4 Praziquantel API Sales and Marketing
7.4.1 Praziquantel API Sales Channels
7.4.2 Praziquantel API Distributors
7.5 Praziquantel API Customers
8 Praziquantel API Market Dynamics
8.1 Praziquantel API Industry Trends
8.2 Praziquantel API Market Drivers
8.3 Praziquantel API Market Challenges
8.4 Praziquantel API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
